This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
On 30 June, NSW Health announced that free flu shots for NSW residents will be extended until 17 July amid concerns vaccination rates are still not where they should be. The NSW Health Minister has urged families to use the school holidays to book in for a free flu shot for children as well as adults.
Diphtheria cases in NSW
On 2 July a case of diphtheria was confirmed in a two year old child in Northern NSW – the first case of diphtheria of the throat in NSW in a century. A second case of diphtheria of the throat in a six year old child was confirmed on 3 July. Both children were not vaccinated against diphtheria.
Diphtheria is very rare in Australia however, the disease has very serious outcomes and can be fatal. Immunisation providers are encouraged to be alert and review children’s immunisation status.
The diphtheria vaccine is free for children on the NIP at six weeks, four months, six months, 18 months, four years, and at the beginning of high school. In adulthood, diphtheria vaccine is recommended for adults every 10 years and in pregnancy.
Communicating with people who are unvaccinated against COVID-19
This brief NCIRS report summarises perspectives on COVID-19 vaccines of unvaccinated adults living in Australia who were interviewed in late 2021. Informed by these findings, the recommendations aim to improve communication between health authorities, immunisation providers, and unvaccinated individuals and their friends and families.
Be ready to tailor conversations to a range of positions on vaccination, from refusing to hesitant about the COVID-19 vaccines (including receiving a booster vaccine)
Sharing Knowledge About Immunisation (SKAI) Healthcare Providers Survey
NCIRS is currently evaluating two websites that provide information and resources to support better conversations about vaccination. The survey is focussed on routinely recommended vaccinations for pregnancy and early childhood. It does not focus on vaccinations for COVID-19.
Providers are encouraged to complete the survey to help NCIRS understand:
your vaccination communication needs
your interest in vaccination communication training
your impressions of the websites now
your ideas on how to improve the websites.
Current wave of infections in NSW driven by Omicron BA.4 and BA.5
COVID-19 transmission in the community remains high, according to the latest Respiratory Surveillance Report. It is expected BA.4 and BA.5 will become dominant in the coming weeks and are likely to be associated with an increase in COVID-19 infections including an increase in reinfections.
NSW Health is urging people to remain COVID-safe this winter by:
staying up to date with vaccinations – for both flu and COVID-19
practising good hand hygiene, physical distancing and wearing a mask
taking a COVID-19 test straight away and self-isolating if unwell
Novavax as a booster
On 1 July, ATAGI updated their clinical guidance on use of Novavax COVID-19 vaccine as a booster dose. Although not preferred, Novavax can be used as a booster dose in people 18 years and older in the following circumstances:
people who have a contraindication to mRNA vaccines (including those who have had a serious adverse event following mRNA vaccines)
At this time, healthy people aged 16 to 64 years who do not have a risk factor for severe COVID-19 are not recommended to receive a winter booster after their first booster. This infographic summarises who should get primary, booster and winter booster doses.
ATAGI recommends that the following people should receive a winter booster of COVID-19 vaccine:
adults aged 65 years and older
Aboriginal and Torres Strait Islander adults aged 50 years and older
residents aged 16 years and older (aged care or disability care facilities)
people aged 16 years and older with severe immunocompromise as defined by ATAGI
people aged 16-64 years who have conditions that increase their risk of severe illness from COVID-19.
The second booster should be received four months after the first booster dose. For people who have been infected with COVID-19, the second booster dose should be delayed until three months after their infection.
Proposed changes to MenB vaccine recommendations
ATAGI is consulting with stakeholders on proposed changes to recommended use of meningococcal B vaccines in people at increased risk of meningococcal B disease.
The draft recommendations and the rationale for the changes are outlined the public consultation document available on the Department of Health and Aged Care website. Deadline for submission is 11.59PM on Sunday 17 July 2022.
Zostavax (shingles vaccine) supply issues
Zostavax remains restricted due to national supply shortages. To ensure ongoing supply to all immunisation providers, ordering quantities will be restricted from the NSW State Vaccine Centre until supply issues stabilise.
CESPHN ANI Scholarship for General Practice nurses
Central and Eastern Sydney PHN is offering registered nurses working in General Practice within the CESPHN region the opportunity to apply for a scholarship to complete studies to become a qualified authorised nurse immuniser (ANI) in NSW and administer vaccinations independent of a medical officer.
CESPHN are offering successful applicants 100% scholarship to this course (valued at $350). If you are interested in applying, ensure you meet eligibility criteria and apply here. Applications close 31 July 2022.
Upcoming immunisation webinars
Pneumococcal Disease 2022 webinar
Details: Wednesday 20 July | 6.00pm to 7.00pm AEST
Topic: the latest facts about pneumococcal disease, currently available vaccines, the NIP and the PneumoSmart Vaccination Tool created to assist GPs, practice nurses, and other Immunisation providers to comply with the Australian Immunisation Handbook recommendations
Details: Wednesday 6 July | 7.00pm to 8.00pm AESTOR Thursday 7 July | 1:00pm to 2:00pm AEST
Topic: this webinar will take a case-based approach to address low vaccine confidence and provide strategies to identify and engage patients who refuse vaccines. Presented by A/Prof Holly Seale (Social Scientist) and Dr Damian Flanagan (GP)
CPD: The 1 hour webinar is RACGP accredited for 2 CPD points
GP weekly webinar: booster doses and influenza vaccines
Details: Thursday 7 July 2022 | 11:30am AEST
Topic: primary care update on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. GPs and all health professionals are welcome.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…